David Warshal

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer”.

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.578

N/A

0.399DataRank · unranked

12 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Mark S. Reed, Melanie K Bergman +21 more

Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.016

N/A

0DataRank · unranked

3 citations

Minxing Chen, Michael T. Walsh, Amanda L. Eppolito, Molly H. Klein, Kelly B. Teed +51 more

Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.005

N/A

0DataRank · unranked

13 citations

Helen Huang, Bradley J. Monk, Yong-Beom Kim, Moon‐Hong Kim, Paul DiSilvestro +17 more

Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.023

N/A

0DataRank · unranked

10 citations

Helen Huang, Bradley J. Monk, Yong-Beom Kim, Moon-Hong Kim, Ashley Stuckey +14 more

105P Immune biomarker analysis of the OVATION-2 trial, a randomized phase I/II study of IL-12 gene therapy IMNN-001 in combination with neo/adjuvant chemotherapy (NACT) in newly-diagnosed advanced epithelial ovarian cancer (EOC)

ESMO Open(2025)10.1016/j.esmoop.2025.105233

N/A

0DataRank · unranked

1 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Bhavana Pothuri, Jennifer Scalici +14 more

Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.094

N/A

0DataRank · unranked

0 citations

Danielle Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Matthew Powell +19 more